Literature DB >> 10052935

Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene.

Y Wu1, T A Craig, W H Lutz, R Kumar.   

Abstract

Transforming growth factor-beta (TGF-beta) is one of the most abundant growth factors secreted by bone cells, and regulation of TGF-beta expression is crucial for bone development and growth. Previous studies from our laboratory demonstrated that 1 alpha, 25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) inhibits human osteoblast and keratinocyte growth by increasing TGF-beta2 secretion and synthesis. To examine the mechanism by which 1 alpha,25(OH)2D3 regulates TGF-beta 2 transcription in osteoblasts, we ligated segments of the human TGF-beta 2 promoter 5' of a growth hormone reporter gene in a growth hormone reporter plasmid and examined the effects of 1 alpha,25(OH)2D3 administration on the expression of growth hormone in cells transfected with such chimeric promoter-reporter plasmids. The promoter region extending from -973 to +68 bp of the transcription start site elicited a 7-fold increase in reporter gene activity in transiently transfected osteoblasts after 1 alpha,25(OH)2D3 treatment, whereas the region from -553 to +68 bp of the transcription start site showed no response following 1 alpha,25(OH)2D3 treatment. Transfection of osteoblasts with reporter plasmids containing TGF-beta 2 promoter DNA from -869 to -658 bp revealed a 3.8-fold increase in reporter gene activity. DNA fragments from this region (-743 to -676 bp and -786 to -728 bp) ligated into reporter plasmids also showed increases in reporter activity. Gel retardation assay experiments showed that DNA fragments from -774 to -735 bp and -714 to -675 bp both formed a DNA-protein complex with bacterially expressed human retinoic acid X receptor alpha (RXR alpha) and vitamin D receptor (VDR) and with nuclear extracts from human bone cells. Addition of a vitamin D receptor antibody to reactions containing the aforesaid DNA fragments and bone cell nuclear extract resulted in further retardation of the mobility of the DNA-protein complex (super-shifting). Removal of two putative direct repeat DNA fragments in this region abolished VDR-RXR alpha-vitamin D response element complex formation. The TGF-beta 2 promoter contains two imperfect direct repeat DNA sequences: TGTAGAACAAGTAGA and AATGAAGTTGGTGGA that mediate the effect of 1 alpha,25(OH)2D3.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10052935     DOI: 10.1021/bi981944s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Detection of 1α,25-dihydroxyvitamin D-regulated miRNAs in zebrafish by whole transcriptome sequencing.

Authors:  Theodore A Craig; Yuji Zhang; Andrew T Magis; Cory C Funk; Nathan D Price; Stephen C Ekker; Rajiv Kumar
Journal:  Zebrafish       Date:  2014-03-20       Impact factor: 1.985

3.  Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.

Authors:  M D Griffin; W Lutz; V A Phan; L A Bachman; D J McKean; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

4.  HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling.

Authors:  Cassandra A Godman; Rashmi Joshi; Brendan R Tierney; Emily Greenspan; Theodore P Rasmussen; Hsin-Wei Wang; Dong-Guk Shin; Daniel W Rosenberg; Charles Giardina
Journal:  Cancer Biol Ther       Date:  2008-10-07       Impact factor: 4.742

Review 5.  Vitamin D for the prevention and treatment of pancreatic cancer.

Authors:  Kun-Chun Chiang; Tai C Chen
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

6.  Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial.

Authors:  Huakang Tu; W Dana Flanders; Thomas U Ahearn; Carrie R Daniel; Amparo G Gonzalez-Feliciano; Qi Long; Robin E Rutherford; Roberd M Bostick
Journal:  Mol Carcinog       Date:  2013-10-26       Impact factor: 4.784

7.  Elevated transforming growth factor beta2 enhances apoptosis and contributes to abnormal outflow tract and aortic sac development in retinoic X receptor alpha knockout embryos.

Authors:  Steven W Kubalak; D Reneé Hutson; Karen K Scott; Rebecca A Shannon
Journal:  Development       Date:  2002-02       Impact factor: 6.868

8.  A Marfan syndrome gene expression phenotype in cultured skin fibroblasts.

Authors:  Zizhen Yao; Jochen C Jaeger; Walter L Ruzzo; Cecile Z Morale; Mary Emond; Uta Francke; Dianna M Milewicz; Stephen M Schwartz; Eileen R Mulvihill
Journal:  BMC Genomics       Date:  2007-09-12       Impact factor: 3.969

9.  Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis.

Authors:  Xi Zhang; Xuan-Zhang Huang; Wen-Jun Chen; Jian Wu; You Chen; Cong-Cong Wu; Zhen-Ning Wang
Journal:  Oncotarget       Date:  2017-06-29

10.  Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.

Authors:  Pedro L F Costa; Monica M França; Maria L Katayama; Eduardo T Carneiro; Regina M Martin; Maria A K Folgueira; Ana C Latronico; Bruno Ferraz-de-Souza
Journal:  Cells       Date:  2019-04-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.